相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells
Vera Damuzzo et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2015)
Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients
Jingwei Jiang et al.
HUMAN IMMUNOLOGY (2014)
Quantification of Blood Dendritic Cells in Colorectal Cancer Patients During the Course of Disease
Giulia Orsini et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients
Anne Waschbisch et al.
PLOS ONE (2014)
Myeloid-Derived Suppressor Cells in the Development of Lung Cancer
Myrna L. Ortiz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients
Mark A. Jensen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
Kimberly R. Jordan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation
Hanna Dobrowolska et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Plasmacytoid Dendritic Cells in Patients With Autoimmune Thyroid Disease
Susanna Leskela et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients
Marlies E. Heuvers et al.
LUNG CANCER (2013)
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
Marlies E. Heuvers et al.
BMC CANCER (2012)
Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
On the armament and appearances of human myeloid-derived suppressor cells
Isabel Poschke et al.
CLINICAL IMMUNOLOGY (2012)
The Role of a Disturbed Arginine/NO Metabolism in the Onset of Cancer Cachexia: A Working Hypothesis
N. Buijs et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3
George Vlad et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ Cells
Guanqun Ge et al.
TRANSPLANT IMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus
S. Chen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k) A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCE
Hao Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis Emphasis on Non-small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Membrane and Soluble ILT3 Are Critical to the Generation of T Suppressor Cells and Induction of Immunological Tolerance
George Vlad et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b(+)/CD14(-)/CD15(+)/CD33(+) myeloid-derived suppressor cells and CD8(+) T lymphocytes in patients with advanced-stage non-small cell lung cancer
Chien-Ying Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b
Mark A. Jensen et al.
MULTIPLE SCLEROSIS (2010)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
CD8+ T suppressor cells and the ILT3 master switch
George Vlad et al.
HUMAN IMMUNOLOGY (2008)
Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia
Adriana. I. Colovai et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2007)
Central role of ILT3 in the T suppressor cell cascade
Nicole Suciu-Foca et al.
CELLULAR IMMUNOLOGY (2007)
Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients
Nicole Suciu-Foca et al.
JOURNAL OF IMMUNOLOGY (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of th anergy and differentiation of CD8+ T suppressor cells
Seunghee Kim-Schulze et al.
JOURNAL OF IMMUNOLOGY (2006)
Tolerization of dendritic cells by T-S cells: the crucial role of inhibitory receptors ILT3 and ILT4
CC Chang et al.
NATURE IMMUNOLOGY (2002)
分享论文
